A Comparative Analysis of the Immunotranscriptomic Features of DENV-1, -3, and -4 Human Challenge Models
Céline S C Hardy, Lisa A. Ware, Heather Friberg, Joel V. Chua et autres
0 citationsThe Journal of Infectious Diseases
Kirsten E. Lyke
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
165Publications signalées
14184Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Malaria Research and ControlMosquito-borne diseases and controlvaccines and immunoinformatics approachesSARS-CoV-2 and COVID-19 ResearchComplement system in diseases
Publications récentes
Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial
Justin R. Ortiz, Drishya Kurup, A Kaufman, Sabrine Ben Hamed et autres
1 citationNature Medicine
Distinct Plasmodium falciparum Erythrocyte Membrane Protein 1 Domain Cassette-Associated Antibody Gaps Specific to Cerebral Malaria and Severe Malarial Anemia
Mark A. Travassos, Paul Han, D Coulibaly, Emily M. Stucke et autres
1 citationThe Journal of Infectious Diseases
Cellular and molecular interactions underlying the peripheral immune responses to blood-stage malaria infections
Kieran Tebben, Rosita R. Asawa, David Serre, Kirsten E. Lyke
0 citationsImmunoHorizons
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost
Noemia S. Lima, Lauren McCormick, Samuel Li, Christian Wake et autres
0 citationsScience Translational Medicine
A comparative analysis of the immunotranscriptomic features of DENV-1, -3, and -4 human challenge models
Céline Hardy, Lisa A. Ware, Heather Friberg, Joel V Chua et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Novel Dengue Serotype 4 Live Virus Human Challenge: A Phase 1 Dose Optimization and Homologous Rechallenge Study
Joel V Chua, Angie Price, Salma Sharaf, Sigrid Camacho Ortega et autres
0 citationsSSRN Electronic Journal
Characterizing the pharmacokinetics of MAM01, an extended half-life monoclonal antibody for the prevention of malaria using a population approach
Ahmed A. Abulfathi, Mirjam N. Trame, Micha Levi, James W. Huleatt et autres
0 citations
Linear Epitope-Based Biomarkers for Improved Dengue Virus Serodiagnostic Applications
Johanna Bouckaert, Francesca Falconi‐Agapito, Johan Míchiels, Marharyta Krauchuk et autres
0 citationsSSRN Electronic Journal
Plasmodium falciparum gene expression signatures and antibody profiling implicate the fikk, phist, and surf multigene families in severe malaria syndromes
Emily M. Stucke, Drissa Coulibaly, Jonathan G. Lawton, Rafal S. Sobota et autres
2 citationsJournal of Infection
First-in-Human Dengue Serotype 4 Live Virus Human Challenge: A Phase 1 Dose Optimization and Homologous Rechallenge Study
Joel V. Chua, Angie Price, Salma Sharaf, Sigrid Camacho Ortega et autres
2 citationsResearch Square
Immunogenicity of an adjuvanted, combination inactivated rabies-vectored, Lassa fever vaccine in healthy adults: interim results of a first-in-human Phase 1 trial
Justin R. Ortiz, Drishya Kurup, A Kaufman, Sabrine Ben Hamed et autres
0 citationsmedRxiv
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.